Lazard Asset Management LLC Purchases 22,814 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Lazard Asset Management LLC increased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 42.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,107 shares of the company's stock after acquiring an additional 22,814 shares during the period. Lazard Asset Management LLC's holdings in Option Care Health were worth $1,788,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. JPMorgan Chase & Co. lifted its stake in Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after purchasing an additional 344,875 shares during the last quarter. MetLife Investment Management LLC raised its holdings in shares of Option Care Health by 7.8% during the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock worth $4,575,000 after buying an additional 14,311 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after buying an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. lifted its position in shares of Option Care Health by 38.1% during the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock worth $1,596,000 after buying an additional 18,992 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Option Care Health during the 4th quarter worth $327,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Insider Buying and Selling

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Trading Down 1.3%

Shares of Option Care Health stock traded down $0.40 on Friday, hitting $31.63. The stock had a trading volume of 139,768 shares, compared to its average volume of 2,013,707. The stock has a 50 day moving average of $33.05 and a 200 day moving average of $29.24. The firm has a market capitalization of $5.18 billion, a P/E ratio of 26.57, a PEG ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company's revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.26 EPS. Sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on the company. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. raised their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.